Cryptococcal Meningitis: Clinical Trials

1 trial for Cryptococcal Meningitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Unknown 1

Follow Cryptococcal Meningitis: new trials by email Literature Review of Cryptococcal Meningitis trials Research Report on Cryptococcal Meningitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Three Induction Treatments on Cryptococcal Meningitis
Voriconazole 200mg, amphotericin B deoxycholate (0.4-0.5mg/kg/d), Amphotericin B-deoxycholate (0.7-1.0mg/kg/d) - Cryptococcal Meningitis, HIV/AIDS
Early Phase 1UnknownFirst Affiliated Hospital of Zhejiang University1202021-01-252021-02-02

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  Meningitis, Cryptococcal (1)

Broader conditions

Bacterial Infections and Mycoses (1)  ·  Blood-Borne Infections (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Fungal Infections (1)  ·  Central Nervous System Infections (1)  ·  Communicable Diseases (1)  ·  Cryptococcosis (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Meningitis (1)  ·  Meningitis, Fungal (1)

Interventions

Voriconazole (1)  ·  amphotericin B, deoxycholate drug combination (1)

Sponsors

First Affiliated Hospital of Zhejiang University (1)

Countries

China (1)

Top investigators

Lijun Xu, PH.D (1)